Cerebrovascular disorders (cerebral infarction, transient ischemic attack, cerebral hemorrhage, asymptomatic extracranial/intracranial steno-occlusion, subarachnoid hemorrhage, cerebral arteriovenous malformation, dural arteriovenous fistula, venous sinus thrombosis, moyamoya disease, reversible cerebral vasospasm syndrome)
Conditions
Interventions
None listed
Sponsors
National Cerebral and Cardiovascular Center
Department of Neurology, Graduate School of Medicine, Mie University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Aged 20 years or older Patients with cerebrovascular disease admitted to the institutes within 7 days from symptom onset or the last-known-well date Patients with the provision of written informed consent for RNF213 p.R4810K genotyping examination and a comprehensive consent form for the NCVC Biobank
Exclusion criteria
Exclusion criteria: Patients deemed by the physician to be ineligible for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate of ischemic events during the observation period | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of bleeding events, all-cause mortality, and cardiovascular death during the observation period | — |
Countries
Japan
Contacts
Public ContactTakeshi Yoshimoto
National Cerebral and Cardiovascular Center Department of Neurology
Outcome results
None listed